Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

What we know about estrogen's effect on the brain.

Julie L Mitchell1

  • 1Division of Internal Medicine, Department of Medicine, Medical College of Wisconsin, 8701 Watertown Plan Road, Milwaukee, WI 5322, USA. jmitchel@mcw.edu

Current Women'S Health Reports
|September 7, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of cross-stage, cross-species malaria CD8<sup>+</sup> T cell antigens.

Nature·2026
Same author

Rapid and profound decay of inducible and intact HIV genomes in early-treated Thai children.

The Journal of clinical investigation·2026
Same author

Dynamic changes in immune cell subsets in blood and lymph node over the course of acute HIV infection.

Journal of virus eradication·2025
Same author

Activation of CXCR3<sup>+</sup> Tfh cells and B cells in lymph nodes during acute HIV-1 infection correlates with HIV-specific antibody development.

Journal of virology·2025
Same author

Initial productive and latent HIV infections originate in vivo by infection of resting T cells.

The Journal of clinical investigation·2023
Same author

An active HIV reservoir during ART is associated with maintenance of HIV-specific CD8<sup>+</sup> T cell magnitude and short-lived differentiation status.

Cell host & microbe·2023

Estrogen therapy shows limited evidence for improving cognition or preventing dementia in aging populations. A large trial found no benefit for women with mild to moderate Alzheimer's disease.

Area of Science:

  • Neuroscience
  • Gerontology
  • Endocrinology

Background:

  • Cognitive impairment and Alzheimer's disease (AD) are significant concerns in aging populations.
  • Estrogen's potential neuroprotective effects are suggested, but clinical evidence for hormone therapy (HT) in cognition and dementia is inconclusive.
  • Existing studies face challenges like accurate dementia diagnosis, cognitive testing confounding, and bias in observational research (e.g., healthy user effect).

Purpose of the Study:

  • To evaluate the efficacy of estrogen in preserving cognitive function.
  • To determine if estrogen therapy can prevent the onset of Alzheimer's disease.
  • To assess the impact of estrogen on functional outcomes in women already diagnosed with Alzheimer's disease.

Main Methods:

  • Review of existing studies on estrogen and cognition, including observational and randomized controlled trials (RCTs).

Related Experiment Videos

  • Analysis of data regarding estrogen's effect on general cognitive function in healthy women.
  • Examination of evidence for estrogen's role in preventing Alzheimer's disease, noting limitations in prior studies.
  • Inclusion of results from a large RCT investigating conjugated estrogen in women with mild to moderate Alzheimer's disease.

    • Main Results:

    • Some studies suggest a modest cognitive improvement in generally healthy women, while others show no effect.
    • Observational studies report potential benefits for preventing Alzheimer's disease, but often lack adequate control for confounding factors and RCT data.
    • A significant RCT demonstrated no beneficial effect of conjugated estrogen on clinical outcomes for women with established mild to moderate Alzheimer's disease.

    Conclusions:

    • Current evidence is limited and often conflicting regarding estrogen's benefits for cognitive function and dementia prevention.
    • Randomized controlled trial data are crucial for definitive conclusions, especially for Alzheimer's disease.
    • Estrogen therapy, specifically conjugated estrogen, did not show efficacy in improving clinical outcomes for women with mild to moderate Alzheimer's disease.